| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.28 | 0.1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.098 | 0.1 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |